Products
2660 products
| Code | Description | Unit |
|---|---|---|
| EPY0000487 | Leflunomide impurity A - 4-(trifluoromethyl)aniline | EP unit |
| EPY0000488 | Human immunoglobulin (molecular size) BRP | EP unit |
| EPY0000489 | Mycophenolate mofetil | EP unit |
| EPY0000490 | Misoprostol | EP unit |
| EPY0000493 | Phloroglucinol (anhydrous) | EP unit |
| EPY0000494 | Ruscogenins | EP unit |
| EPY0000495 | Trandolapril impurity C - (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril) | EP unit |
| EPY0000496 | Trandolapril impurity D - ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril diketopiperazine) | EP unit |
| EPY0000497 | Troxerutin | EP unit |
| EPY0000498 | Tylosin phosphate for peak identification | EP unit |
| EPY0000499 | Calcipotriol (anhydrous) - Reference Spectrum | EP unit |
| EPY0000500 | Acarbose | EP unit |
| EPY0000501 | Trandolapril | EP unit |
| EPY0000502 | Human vaccinia immunoglobulin | EP unit |
| EPY0000503 | Atracurium for impurity F identification | EP unit |
| EPY0000504 | Atracurium for peak identification | EP unit |
| EPY0000505 | Cefalotin for impurity B identification | EP unit |
| EPY0000506 | Cefotaxime sodium for peak identification | EP unit |
| EPY0000507 | Chlorpromazine impurity A - 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide (chlorpromazine sulphoxide) | EP unit |
| EPY0000508 | Chlorpromazine impurity E - 2-chloro-10H-phenothiazine | EP unit |
| EPY0000509 | Desogestrel | EP unit |
| EPY0000510 | Desogestrel for system suitability | EP unit |
| EPY0000511 | Dexamethasone isonicotinate for impurity C identification | EP unit |
| EPY0000512 | Emedastine impurity E - 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole | EP unit |
| EPY0000513 | Gemfibrozil | EP unit |
| EPY0000514 | Gemfibrozil for system suitability | EP unit |
| EPY0000515 | Glimepiride | EP unit |
| EPY0000516 | Glimepiride for system suitability | EP unit |
| EPY0000517 | Glutathione | EP unit |
| EPY0000518 | Lamivudine for system suitability 1 | EP unit |
| EPY0000519 | Mycophenolate mofetil for peak identification | EP unit |
| EPY0000520 | Nevirapine (anhydrous) | EP unit |
| EPY0000521 | Nevirapine for peak identification | EP unit |
| EPY0000522 | Norethistherone for system suitability | EP unit |
| EPY0000523 | Glipizide impurity C - ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate | EP unit |
| EPY0000524 | Pamidronate disodium pentahydrate | EP unit |
| EPY0000525 | Pimobendan | EP unit |
| EPY0000527 | Rocuronium for peak identification | EP unit |
| EPY0000528 | Sulbactam | EP unit |
| EPY0000529 | Sulbactam sodium | EP unit |
| EPY0000530 | Sultamicillin | EP unit |
| EPY0000531 | Sultamicillin tosilate | EP unit |
| EPY0000532 | Sultamicillin for peak identification | EP unit |
| EPY0000533 | Valnemulin hydrogen tartrate | EP unit |
| EPY0000534 | Zuclopenthixol for system suitability (Zuclopenthixol decanoate dihydrochloride) | EP unit |
| EPY0000535 | Terbinafine hydrochloride | EP unit |
| EPY0000536 | Carboprost trometamol - Reference Spectrum | EP unit |
| EPY0000537 | Emedastine difumarate | EP unit |
| EPY0000538 | Dexamethasone isonicotinate | EP unit |
| EPY0000540 | Immunoglobulin panel for anti-D antibodies test BRP (2 Amp.) | EP unit |
| EPY0000541 | Thioridazine for system suitability | EP unit |
| EPY0000542 | Nandrolone decanoate | EP unit |
| EPY0000543 | Oxazepam for peak identification | EP unit |
| EPY0000544 | Dihydrotachysterol | EP unit |
| EPY0000545 | Thioctic acid containing impurity B | EP unit |
| EPY0000546 | Thioctic acid | EP unit |
| EPY0000547 | Nandrolone decanoate for peak identification | EP unit |
| EPY0000548 | Nandrolone decanoate for system suitability | EP unit |
| EPY0000549 | Spectinomycin for system suitability | EP unit |
| EPY0000550 | Sulbactam for peak identification | EP unit |
| EPY0000551 | Doxazosin impurity D - 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione | EP unit |
| EPY0000552 | Doxazosin impurity F - 2-chloro-6,7-dimethoxyquinazolin-4-amine | EP unit |
| EPY0000553 | Doxazosin mesilate | EP unit |
| EPY0000554 | Digoxin for peak identification | EP unit |
| EPY0000555 | Iotrolan | EP unit |
| EPY0000556 | Febantel | EP unit |
| EPY0000557 | Fluconazole | EP unit |
| EPY0000558 | Fluconazole for peak identification | EP unit |
| EPY0000559 | Clobetasol propionate | EP unit |
| EPY0000560 | Oxacillin for peak identification | EP unit |
| EPY0000561 | Vecuronium bromide | EP unit |
| EPY0000562 | Midazolam impurity C - acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylique | EP unit |
| EPY0000563 | Amitriptyline hydrochloride | EP unit |
| EPY0000564 | Bendroflumethiazide impurity A - 4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide | EP unit |
| EPY0000565 | beta-Acetyldigoxin | EP unit |
| EPY0000568 | Cefradine for peak identification | EP unit |
| EPY0000569 | Chlorogenic acid | EP unit |
| EPY0000570 | Clobetasol for peak identification | EP unit |
| EPY0000571 | Clobetasol impurity J - (17R)-4'-chloro-5'-ethyl-9-fluoro-11ß-hydroxy-16ß-methylspiro[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound) | EP unit |
| EPY0000572 | Etidronate disodium | EP unit |
| EPY0000573 | Fluconazole impurity B - 2-[2-fluro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol | EP unit |
| EPY0000574 | Fluconazole impurity C - 1,1'-(1,3-phenylene)di-1H-1,2,4-triazole | EP unit |
| EPY0000577 | Pancuronium bromide for system suitability | EP unit |
| EPY0000578 | Paroxetine hydrochloride (anhydrous) | EP unit |
| EPY0000579 | Paroxetine hydrochloride (anhydrous) impurity C - (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine (N-benzylparoxetine) | EP unit |
| EPY0000580 | Paroxetine impurity E - (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine) | EP unit |
| EPY0000581 | Paroxetine hydrochloride (anhydrous) impurity H - [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol | EP unit |
| EPY0000582 | Prednisolone acetate for peak identification | EP unit |
| EPY0000583 | Valerian standardised dry extract | EP unit |
| EPY0000584 | Valnemulin hydrochloride | EP unit |
| EPY0000585 | Valnemulin for peak identification | EP unit |
| EPY0000586 | Valnemulin impurity E - (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin) | EP unit |
| EPY0000587 | Venlafaxine hydrochloride | EP unit |
| EPY0000588 | Venlafaxine for system suitability | EP unit |
| EPY0000589 | Vinpocetine | EP unit |
| EPY0000590 | Vinpocetine impurity A - (12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (ethyl vincaminate) | EP unit |
| EPY0000591 | Vinpocetine impurity B - (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine) | EP unit |
| EPY0000592 | Thioctic acid for system suitability | EP unit |
| EPY0000593 | Chondroitin sulphate sodium (marine) | EP unit |
| EPY0000595 | Alverine for peak identification | EP unit |